Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2022 | 07-2022 | 04-2022 | 01-2022 | 10-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,135 | 21,603 | 31,130 | 4,159 | 6,356 |
| Marketable Securities | N/A | N/A | 0 | 29,480 | 29,810 |
| Receivables | 11,515 | 4,762 | 11,761 | 15,316 | 11,332 |
| Inventories | 15,787 | 9,516 | 14,934 | 13,851 | 13,957 |
| Other current assets | 0 | 4,126 | 0 | 0 | 0 |
| TOTAL | $44,579 | $42,823 | $62,299 | $66,710 | $65,912 |
| Non-Current Assets | |||||
| PPE Net | 17,140 | 11,636 | 17,545 | 17,527 | 16,953 |
| Intangibles | 7,452 | 0 | 7,481 | 7,552 | 7,623 |
| Other Non-Current Assets | 16,028 | 21,152 | 16,579 | 17,033 | 17,651 |
| TOTAL | $40,620 | $32,788 | $41,605 | $42,112 | $42,227 |
| Total Assets | $85,199 | $75,611 | $103,904 | $108,822 | $108,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,109 | 3,715 | 7,664 | 6,860 | 5,929 |
| Accrued Expenses | 12,377 | 8,179 | 13,629 | 15,865 | 13,577 |
| Other current liabilities | 312 | 229 | 238 | 236 | 235 |
| TOTAL | $24,253 | $13,019 | $24,702 | $26,148 | $23,106 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,986 | 4,077 | 4,177 | 4,270 | 4,314 |
| Other Non-Current Liabilities | 11,970 | 4,053 | 12,779 | 13,199 | 13,959 |
| TOTAL | $15,956 | $8,130 | $17,015 | $17,548 | $18,273 |
| Total Liabilities | $40,209 | $21,149 | $41,717 | $43,696 | $41,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,720 | 48,720 | 48,720 | 48,709 | 48,472 |
| Common Shares | 487 | 487 | 487 | 485 | 485 |
| Retained earnings | -299,273 | -288,638 | -280,205 | -275,351 | -272,696 |
| Other shareholders' equity | 3,884 | 3,151 | 2,882 | 1,971 | 1,629 |
| TOTAL | $44,990 | $54,462 | $62,187 | $65,126 | $66,760 |
| Total Liabilities And Equity | $85,199 | $75,611 | $103,904 | $108,822 | $108,139 |